rpoB mutations and their association with rifampicin resistance in clinical Staphylococcus epidermidis.|https://dx.doi.org/10.1093/jac/dkaf035
[Dermatological conditions requiring intensive care treatment].|https://dx.doi.org/10.1007/s00063-024-01239-4
Epidemiology of skin infections in Auckland, New Zealand.|https://dx.doi.org/10.26635/6965.6700
Diabetes potentiates the emergence and expansion of antibiotic resistance.|https://dx.doi.org/10.1126/sciadv.ads1591
Formulation of topical gel contains a novel benzoic acid derivative for skin infection treatment: in vitro and in vivo evaluations.|https://dx.doi.org/10.1080/03639045.2025.2464793
Protection of Mice Vaccinated with a New B Cell and T Cell Epitopes Cocktail from Staphylococcus aureus Challenge in Skin Infection Model.|https://dx.doi.org/10.1007/s00284-025-04102-7
Metabolic analysis of the mode of action and mode of resistance of fusidic acid against Staphylococcus aureus.|https://dx.doi.org/10.1093/femsle/fnaf011
